Page last updated: 2024-08-23

diaziquone and Abnormalities, Autosome

diaziquone has been researched along with Abnormalities, Autosome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bloomfield, CD; Carroll, AJ; Edwards, CG; Kolitz, JE; Larson, RA; Maharry, K; Marcucci, G; Mayer, RJ; Moore, JO; Mrózek, K; Pettenati, MJ; Powell, BL; Ruppert, AS; Schiffer, CA; Sterling, LJ; Vardiman, JW	1
Allen, JW; Erexson, GL; Kligerman, AD	1

Other Studies

2 other study(ies) available for diaziquone and Abnormalities, Autosome

Article	Year
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-20, Volume: 23, Issue:24 Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Statistics, Nonparametric; Survival Analysis	2005
Diaziquone-induced micronuclei in cytochalasin B-blocked mouse peripheral blood lymphocytes. Mutation research, 1987, Volume: 178, Issue:1 Topics: Animals; Aziridines; Azirines; Benzoquinones; Cell Cycle; Cell Nucleus; Chromosome Aberrations; Cytochalasin B; Dose-Response Relationship, Drug; Leukocyte Count; Lymphocytes; Male; Mice; Mutagenicity Tests	1987

Article

Year

Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-20, Volume: 23, Issue:24

Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Statistics, Nonparametric; Survival Analysis

2005

Diaziquone-induced micronuclei in cytochalasin B-blocked mouse peripheral blood lymphocytes.

Mutation research, 1987, Volume: 178, Issue:1

Topics: Animals; Aziridines; Azirines; Benzoquinones; Cell Cycle; Cell Nucleus; Chromosome Aberrations; Cytochalasin B; Dose-Response Relationship, Drug; Leukocyte Count; Lymphocytes; Male; Mice; Mutagenicity Tests

1987